
|Articles|November 12, 2021
Poll results: What pipeline presbyopia treatment are you most looking forward to?
Author(s)Brooke Henson, Editor
See our latest poll results
Advertisement
Optometry Times® polled our audience with the following question from October 22, 2021 to November 5, 2021:
The poll appeared on
81 ODs responded, in total. Of these:
- 1 responded "Orasis CSF-1"
- 5 responded "Allergan AGN-190584 drop"
- 3 responded "Eyenovia MicroLine drop"
- 1 responded "Presbyopia Therapies PRX-100"
- 2 responded "Ocuphire Pharma Nyxol"
- 69 responded "Visus Therapeutics Brimochol"
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Simplifying the treatment of ocular surface disease
2
Classifying dry eye by root cause: A step toward precision medicine
3
3D-printed contact lenses offer patient-specific fit in 20 minutes
4
Atropine, aspherical lenses enter trial for childhood myopia
5






















